Your browser doesn't support javascript.
loading
Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages.
Han, Hyo-Won; Seo, Hyang-Hee; Jo, Hye-Yeong; Han, Hyeong-Jun; Falcão, Virgínia C A; Delorme, Vincent; Heo, Jinyeong; Shum, David; Choi, Jang-Hoon; Lee, Jin-Moo; Lee, Seung Hun; Heo, Hye-Ryeon; Hong, Seok-Ho; Park, Mi-Hyun; Thimmulappa, Rajesh K; Kim, Jung-Hyun.
Affiliation
  • Han HW; Division of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea; National Stem Cell Bank of Korea, Korea Institute of Health, Cheongju 28160, Republic of Korea.
  • Seo HH; Division of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea; National Stem Cell Bank of Korea, Korea Institute of Health, Cheongju 28160, Republic of Korea.
  • Jo HY; Division of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea; National Stem Cell Bank of Korea, Korea Institute of Health, Cheongju 28160, Republic of Korea.
  • Han HJ; Division of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea.
  • Falcão VCA; Tuberculosis Research Laboratory, Discovery Biology, Institute Pasteur Korea, Seongnam 13488, Republic of Korea.
  • Delorme V; Tuberculosis Research Laboratory, Discovery Biology, Institute Pasteur Korea, Seongnam 13488, Republic of Korea.
  • Heo J; Screening Discovery Platform, Screening Sciences and Novel Assay Technologies, Institute Pasteur Korea, Seongnam 13488, Republic of Korea.
  • Shum D; Screening Discovery Platform, Screening Sciences and Novel Assay Technologies, Institute Pasteur Korea, Seongnam 13488, Republic of Korea.
  • Choi JH; Division of Viral Disease Research, Center for Infectious Diseases Research, National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea.
  • Lee JM; Division of Viral Disease Research, Center for Infectious Diseases Research, National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea.
  • Lee SH; Division of Bacterial Disease Research, Center for Infectious Disease Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea.
  • Heo HR; Department of Internal Medicine, School of Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea.
  • Hong SH; Department of Internal Medicine, School of Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea.
  • Park MH; Division of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea; National Stem Cell Bank of Korea, Korea Institute of Health, Cheongju 28160, Republic of Korea.
  • Thimmulappa RK; Department of Biochemistry, Center of Excellence in Molecular Biology and Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru 570015, India.
  • Kim JH; Division of Intractable Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Republic of Korea; National Stem Cell Bank of Korea, Korea Institute of Health, Cheongju 28160, Republic of Korea. Electronic addres
Stem Cell Reports ; 13(6): 980-991, 2019 12 10.
Article in En | MEDLINE | ID: mdl-31680058

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Evaluation, Preclinical / Drug Discovery / Human Embryonic Stem Cells / Macrophages / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Stem Cell Reports Year: 2019 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Evaluation, Preclinical / Drug Discovery / Human Embryonic Stem Cells / Macrophages / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Stem Cell Reports Year: 2019 Document type: Article Country of publication: